PURPOSE: To investigate the hypothesis that non-steroidal anti-inflammatory drugs (NSAIDs) lower lung cancer risk. METHODS: We analysed pooled individual-level data from seven case-control and one cohort study in the International Lung Cancer Consortium (ILCCO). Relative risks for lung cancer associated with self-reported history of aspirin and other NSAID use were estimated within individual studies using logistic regression or proportional hazards models, adjusted for packyears of smoking, age, calendar period, ethnicity and education and were combined using random effects meta-analysis. RESULTS: A total of 4,309 lung cancer cases (mean age at diagnosis 65 years, 45% adenocarcinoma and 22% squamous-cell carcinoma) and 58,301 non-cases/controls were included. Amongst controls, 34% had used NSAIDs in the past (81% of them used aspirin). After adjustment for negative confounding by smoking, ever-NSAID use (affirmative answer to the study-specific question on NSAID use) was associated with a 26% reduction (95% confidence interval 8 to 41%) in lung cancer risk in men, but not in women (3% increase (-11% to 30%)). In men, the association was stronger in current and former smokers, and for squamous-cell carcinoma than for adenocarcinomas, but there was no trend with duration of use. No differences were found in the effects on lung cancer risk of aspirin and non-aspirin NSAIDs. CONCLUSIONS: Evidence from ILCCO suggests that NSAID use in men confers a modest protection for lung cancer, especially amongst ever-smokers. Additional investigation is needed regarding the possible effects of age, duration, dose and type of NSAID and whether effect modification by smoking status or sex exists.
PURPOSE: To investigate the hypothesis that non-steroidal anti-inflammatory drugs (NSAIDs) lower lung cancer risk. METHODS: We analysed pooled individual-level data from seven case-control and one cohort study in the International Lung Cancer Consortium (ILCCO). Relative risks for lung cancer associated with self-reported history of aspirin and other NSAID use were estimated within individual studies using logistic regression or proportional hazards models, adjusted for packyears of smoking, age, calendar period, ethnicity and education and were combined using random effects meta-analysis. RESULTS: A total of 4,309 lung cancer cases (mean age at diagnosis 65 years, 45% adenocarcinoma and 22% squamous-cell carcinoma) and 58,301 non-cases/controls were included. Amongst controls, 34% had used NSAIDs in the past (81% of them used aspirin). After adjustment for negative confounding by smoking, ever-NSAID use (affirmative answer to the study-specific question on NSAID use) was associated with a 26% reduction (95% confidence interval 8 to 41%) in lung cancer risk in men, but not in women (3% increase (-11% to 30%)). In men, the association was stronger in current and former smokers, and for squamous-cell carcinoma than for adenocarcinomas, but there was no trend with duration of use. No differences were found in the effects on lung cancer risk of aspirin and non-aspirin NSAIDs. CONCLUSIONS: Evidence from ILCCO suggests that NSAID use in men confers a modest protection for lung cancer, especially amongst ever-smokers. Additional investigation is needed regarding the possible effects of age, duration, dose and type of NSAID and whether effect modification by smoking status or sex exists.
Authors: Peter M Rothwell; Michelle Wilson; Carl-Eric Elwin; Bo Norrving; Ale Algra; Charles P Warlow; Tom W Meade Journal: Lancet Date: 2010-10-21 Impact factor: 79.321
Authors: Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin Journal: Int J Cancer Date: 2010-12-15 Impact factor: 7.396
Authors: Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman Journal: CA Cancer J Clin Date: 2011-02-04 Impact factor: 508.702
Authors: Christopher G Slatore; David H Au; Alyson J Littman; Jessie A Satia; Emily White Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-03-17 Impact factor: 4.254
Authors: Edward S Kim; Waun K Hong; J Jack Lee; Li Mao; Rodolfo C Morice; Diane D Liu; Carlos A Jimenez; Georgie A Eapen; Reuben Lotan; Ximing Tang; Robert A Newman; Ignacio I Wistuba; Jonathan M Kurie Journal: Cancer Prev Res (Phila) Date: 2010-01-26
Authors: Peter M Rothwell; F Gerald R Fowkes; Jill F F Belch; Hisao Ogawa; Charles P Warlow; Tom W Meade Journal: Lancet Date: 2010-12-06 Impact factor: 79.321
Authors: Julia E Heck; Angeline S Andrew; Tracy Onega; James R Rigas; Brian P Jackson; Margaret R Karagas; Eric J Duell Journal: Environ Health Perspect Date: 2009-07-02 Impact factor: 9.031
Authors: Rayjean J Hung; David C Christiani; Angela Risch; Odilia Popanda; Aage Haugen; Shan Zienolddiny; Simone Benhamou; Christine Bouchardy; Qing Lan; Margaret R Spitz; H-Erich Wichmann; Loic LeMarchand; Paolo Vineis; Giuseppe Matullo; Chikako Kiyohara; Zuo-Feng Zhang; Benhnaz Pezeshki; Curtis Harris; Leah Mechanic; Adeline Seow; Daniel P K Ng; Neonila Szeszenia-Dabrowska; David Zaridze; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Dana Mates; Lenka Foretova; Vladimir Janout; Vladimir Bencko; Neil Caporaso; Chu Chen; Eric J Duell; Gary Goodman; John K Field; Richard S Houlston; Yun-Chul Hong; Maria Teresa Landi; Philip Lazarus; Joshua Muscat; John McLaughlin; Ann G Schwartz; Hongbing Shen; Isabelle Stucker; Kazuo Tajima; Keitaro Matsuo; Michael Thun; Ping Yang; John Wiencke; Angeline S Andrew; Stephanie Monnier; Paolo Boffetta; Paul Brennan Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-11 Impact factor: 4.254
Authors: Sebastiano La Maestra; Francesco D'Agostini; Alberto Izzotti; Rosanna T Micale; Luca Mastracci; Anna Camoirano; Roumen Balansky; James E Trosko; Vernon E Steele; Silvio De Flora Journal: Carcinogenesis Date: 2015-10-13 Impact factor: 4.944
Authors: Thomas J van 't Erve; Fred B Lih; Maria B Kadiiska; Leesa J Deterding; Ronald P Mason Journal: Free Radic Biol Med Date: 2017-11-21 Impact factor: 7.376
Authors: Theodore M Brasky; Christina S Baik; Christopher G Slatore; John D Potter; Emily White Journal: Lung Cancer Date: 2012-05-17 Impact factor: 5.705
Authors: Sonni-Ali Miller; Jason A White; Rupak Chowdhury; Dominique N Gales; Berhanu Tameru; Amit K Tiwari; Temesgen Samuel Journal: J Nutr Intermed Metab Date: 2017-11-22
Authors: Patricia Erickson; Lisa D Gardner; Christopher A Loffredo; Diane Marie St George; Elise D Bowman; Janaki Deepak; Khadijah Mitchell; Claire L Meaney; Patricia Langenberg; Debra H Bernat; Sania Amr; Bríd M Ryan Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-08-31 Impact factor: 4.254
Authors: Darren R Brenner; Dominique Scherer; Kenneth Muir; Joellen Schildkraut; Paolo Boffetta; Margaret R Spitz; Loic Le Marchand; Andrew T Chan; Ellen L Goode; Cornelia M Ulrich; Rayjean J Hung Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-06-24 Impact factor: 4.254
Authors: Theodore M Brasky; Jingmin Liu; Emily White; Ulrike Peters; John D Potter; Roland B Walter; Christina S Baik; Dorothy S Lane; JoAnn E Manson; Mara Z Vitolins; Matthew A Allison; Jean Y Tang; Jean Wactawski-Wende Journal: Int J Cancer Date: 2014-03-20 Impact factor: 7.396